NCT00702078
- Conditions
- COPD, Chronic Disease, Disease Attributes, +6 more
- Locations
-
- Dept. of Lung Diseases, St.Olavs Hospital Trondheim, Norway
Clinical trial condition
Pulmonary Disease, Chronic Obstructive
Explore clinical trials studying Pulmonary Disease, Chronic Obstructive. Study availability and eligibility vary by location and protocol.
4,014 public trials
393 recruiting studies
Pulmonary Disease, Chronic Obstructive trial results
NCT01376245
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- GSK Investigational Site Guangzhou, Guangdong, China
- GSK Investigational Site Guangzhou, Guangdong, China
- GSK Investigational Site Nanning, Guangxi, China
- GSK Investigational Site Changsha, Hunan, China
Completed
A Long-term Safety Study of Fluticasone Furoate (FF)/GW642444 in Japanese Subjects With COPD
NCT01192191
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- GSK Investigational Site Fukuoka, Japan
- GSK Investigational Site Fukuoka, Japan
- GSK Investigational Site Fukushima, Japan
- GSK Investigational Site Gunma, Japan
NCT03017300
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
- Locations
-
Not specified
NCT01636713
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- GSK Investigational Site Gaungzhou, Guangdong, China
- GSK Investigational Site Guangzhou, Guangdong, China
- GSK Investigational Site Zhanjiang, Guangdong, China
- GSK Investigational Site Nanning, Guangxi, China
NCT01120093
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
- Locations
-
- Almirall Investigational Sites#1 Ghent, Belgium
- Almirall Investigational Sites#3 Berlin, Germany
- Almirall Investigational Sites#4 Berlin, Germany
- Almirall Investigational Sites#9 Berlin, Germany
NCT01376388
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- GSK Investigational Site Fukuoka, Japan
- GSK Investigational Site Gunma, Japan
- GSK Investigational Site Hiroshima, Japan
- GSK Investigational Site Hiroshima, Japan
NCT01702363
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- GSK Investigational Site Fukuoka, Japan
- GSK Investigational Site Gunma, Japan
- GSK Investigational Site Hokkaido, Japan
- GSK Investigational Site Hyōgo, Japan
NCT01716520
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- GSK Investigational Site Haapsalu, Estonia
- GSK Investigational Site Tallinn, Estonia
- GSK Investigational Site Tallinn, Estonia
- GSK Investigational Site Tallinn, Estonia
Completed
A Trial Assessing LAS34273 in Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD)
NCT00363896
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
- Locations
-
- Almirall Investigational Sites#947 Les Escaldes, Andorra
- Almirall Investigational Sites#645 Graz, Austria
- Almirall Investigational Sites#646 Innsbruck, Austria
- Almirall Investigational Sites#644 Linz, Austria